Variant report
Variant | esv3428244 |
---|---|
Chromosome Location | chr12:85480533-85503517 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545302701 | chr12:85483605-85483606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs189200539 | chr12:85483606-85483607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569002091 | chr12:85483652-85483653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs143892377 | chr12:85483711-85483712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181957969 | chr12:85483712-85483713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560953562 | chr12:85483724-85483725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531652130 | chr12:85483726-85483727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564586276 | chr12:85483767-85483768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs146433991 | chr12:85483778-85483779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185692337 | chr12:85483803-85483804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs359985 | chr12:85483823-85483824 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs537424284 | chr12:85483873-85483874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191631448 | chr12:85483914-85483915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181260881 | chr12:85483968-85483969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186520595 | chr12:85484012-85484013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs115319423 | chr12:85484047-85484048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536682927 | chr12:85484086-85484087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs115896536 | chr12:85484138-85484139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs117137025 | chr12:85484139-85484140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538816171 | chr12:85484169-85484170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs537691566 | chr12:85486010-85486011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs188178744 | chr12:85486012-85486013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377631906 | chr12:85486050-85486051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571184352 | chr12:85486080-85486081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs74111264 | chr12:85486104-85486105 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs12297183 | chr12:85486109-85486110 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs574936993 | chr12:85486117-85486118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs4761115 | chr12:85486119-85486120 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs558798063 | chr12:85486126-85486127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs370115482 | chr12:85486166-85486167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181763182 | chr12:85486181-85486182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs76698588 | chr12:85486211-85486212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546010032 | chr12:85486244-85486245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs79973953 | chr12:85486306-85486307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184833464 | chr12:85486326-85486327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs572818344 | chr12:85486331-85486332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190218324 | chr12:85486332-85486333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561351249 | chr12:85486352-85486353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528903430 | chr12:85486367-85486368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs537769496 | chr12:85486368-85486369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs78243425 | chr12:85486422-85486423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs181825485 | chr12:85486426-85486427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530984060 | chr12:85486431-85486432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs186438583 | chr12:85486501-85486502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs574299455 | chr12:85486509-85486510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552753037 | chr12:85486541-85486542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs571115144 | chr12:85486568-85486569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs143018718 | chr12:85486577-85486578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs75332993 | chr12:85486579-85486580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs568452452 | chr12:85486580-85486581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:85483600-85484000 | Enhancers | H1 Cell Line | embryonic stem cell |
2 | chr12:85483600-85484000 | Enhancers | H9 Cell Line | embryonic stem cell |
3 | chr12:85483600-85484000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr12:85483600-85484000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr12:85483600-85484000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr12:85483800-85484200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr12:85483800-85484200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
8 | chr12:85486000-85487400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr12:85486200-85487800 | Enhancers | HMEC | breast |
10 | chr12:85486400-85487400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr12:85486600-85486800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr12:85486600-85487200 | Enhancers | NHEK | skin |
13 | chr12:85487000-85487600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
14 | chr12:85490600-85491200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |